Orotracheal Intubation in Newborns: Videolaryngoscopy Vs Direct Laryngoscopy
Launched by TUNIS UNIVERSITY · Oct 22, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is examining two different methods for helping newborns breathe during surgery or intensive care. It compares traditional direct laryngoscopy (DL), where a doctor uses a straight tool to see the airway, with a newer technique called video laryngoscopy (VL), which uses a small camera to provide a clearer view. The goal is to see which method allows doctors to successfully place a breathing tube more quickly and easily.
The trial is open to newborns up to 30 days old who need orotracheal intubation, which means inserting a tube into the windpipe to assist with breathing. Unfortunately, babies older than one month are not eligible. If your child qualifies and participates, they will be randomly assigned to receive one of the two intubation methods after being given anesthesia. This study is currently recruiting participants, and it could help improve the care of newborns needing assistance with breathing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • newborns requiring orotracheal intubation for surgery or mechanical ventilation in the intensive care unit
- Exclusion Criteria:
- • age\> 01 month
About Tunis University
Tunis University is a leading academic institution in Tunisia, dedicated to advancing research and education in various fields, including medicine and health sciences. As a clinical trial sponsor, Tunis University leverages its robust network of researchers, state-of-the-art facilities, and commitment to ethical standards to conduct innovative clinical studies aimed at improving patient outcomes. The university collaborates with local and international partners to facilitate cutting-edge research, fostering an environment of academic excellence and contributing to the global body of medical knowledge. Through its clinical trials, Tunis University aims to address pressing health challenges and enhance the quality of care in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, Tunisia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported